Digipath, Inc. Announces Revenue Increase of Almost 18% for the Fourth Quarter of Fiscal Year 2022
December 8, 2022
Medical Diagnostics & Research
-
-
Digipath Validates and Receives Approval to Use Free DNA Removal to Test for Aspergillus
May 2, 2022
-
Digipath to Provide Product Testing for Redwood Cultivation Products, Including Mike Tyson’s New Ear Shaped Gummies, ‘Mike Bites’
April 4, 2022
-
Digipath Enters Into Validation Agreement with CASPR Technologies to Determine Efficacy for New Anti-Microbial Product for the Cannabis Industry
March 1, 2022
-
Digipath Enters Into Validation Agreement with CASPR Technologies to Determine Efficacy for New Anti-Microbial Product for the Cannabis Industry
March 1, 2022
-
Digipath Announces Financial Results for Q1, 2022
February 15, 2022
-
Digipath Obtains Coveted Compliance Testing License for California Laboratory
February 9, 2022
-
Digipath Obtains Coveted Compliance Testing License for California Laboratory
February 9, 2022
-
Digipath Announces Results for the Fiscal Year 2021
January 4, 2022
-
Grapefruit USA Inc. (GPFT) Unveils New ‘One-Stop Shop’ for Hourglass-Powered Products
May 18, 2021
-
Cannabis Meets Crypto at Grapefruit’s New CBD Hourglass E-Commerce Store
May 18, 2021
-
CBDNewsBreaks – Grapefruit USA Inc. (GPFT) Able to Tailor Hourglass (TM) to Specific Needs
May 17, 2021
-
Grapefruit USA Inc. (GPFT) Releases FY2020 Financial Report, Notes 714% Revenue Growth
May 13, 2021
-
420 with CNW – Limited Medical Cannabis Compromise Bill Sent to Tennessee Governor’s Desk
May 11, 2021